Medical science is undergoing unprecedented innovation. AI is the primary driver of exciting, effective new treatments. Research that took months as recently as a year ago now takes hours or even minutes.

According to the medical databases Medscape and PubMed Central, total human medical knowledge doubles more than once a year:

• 1950: Estimated to double every 50 years

• 1980: Doubled every 7 years

• 2010: Doubled every 3.5 years

• 2020: Expected to double every 73 days

Today, in 2025, with the advent of AI, that rate of doubling has likely increased significantly.

As an example of just one new tool having a profound effect: DeepMind's AlphaFold has created 3D images of essentially every known protein in biology (around 200 million), including all proteins in the human genome. Proteins are major factors in both cancer and Alzheimer's disease. This database is a critical resource for medical researchers, helping them understand disease mechanisms and develop new drugs and vaccines.

Most healthcare institutions resist change. Many have substantial financial and academic interests in maintaining the status quo. They are reluctant to admit, even to themselves, that much of their knowledge is obsolete in a rapidly evolving world.

In a recent test of a simple AI platform designed by Emad Mostaque's company Intelligent Internet Inc., the platform II-Medical scored 48% while physicians, on average, scored 15%. (Learn more on this interesting podcast, Moonshots, here.)

If you are someone with a life-threatening disease, you need to fully understand what is happening with the clinical trials and emerging therapies relevant to your condition. It may be lifesaving.

Groundbreaking research is published daily in hundreds of journals. Clinical trials are scattered across different databases. Advances are being made around the world. Even the most dedicated physicians can't keep up with rapidly changing developments in their field. If they don't know the latest science, they tend to be biased against it. The standard of care is increasingly out of date and irrelevant.

If you are dealing with a life-threatening disease, is the leading edge of medical science that matters.

The reality. . .

The State of the Art in Cancer Research
(As of July 2025)

• The two-page condensed report can be accessed here.

• The fourteen-page summary can be accessed here.

The most interesting new developments in cancer therapy are those that combine precision targeting (of both the tumor and its unique mutations), immunological innovation (like CAR-T and cancer vaccines), and technological advances (AI and liquid biopsies) to deliver more effective, less toxic, and highly personalized treatments. These innovations are rapidly transforming cancer care and offer new hope for patients facing even the most challenging diagnoses.

Increasingly, the most exciting therapies are those where two or more of these treatment protocols are applied simultaneously.

We can find for you the emerging science as it applies to your specific disease. We can identify who is conducting the trials or other research, their credentials and background, and any results to date.

With that information, we'll put together a plan.

We tailor our research to fit each client's specific needs and situation. Options range from free to comprehensive.

• We have a free online Substack, or journal, where we share general insights and discoveries about new developments affecting a wide range of life-threatening medical conditions.

• For a minimal fee, we can let you know when we come across something potentially important and groundbreaking in the treatment of your specific condition. We report at least once every two months; more frequently if we discover something important.

• We can conduct AI research on your behalf into your specific condition and report on relevant trials and emerging therapies. We report at least monthly.

• Our most comprehensive option combines AI research with interviews of leading research scientists and physicians, and provides weekly reports and a conference call to discuss progress. It also includes assistance with enrolling in clinical trials of particular interest.

• We don't just hand you information and walk away—we help you understand what it means and how to use it. We guide you through your treatment options, help you prepare questions for your doctors, and ensure you're making informed decisions each step of the way.

  
  
  

Emerging Cures takes the deluge of complex, cutting-edge medical research—often filled with technical terms—and distills it into clear, concise, and easily understandable summaries. This service makes highly complex scientific information understandable and actionable without the jargon.

Cost

The best place to start is a preliminary call to understand your specific needs and discuss how this research can be tailored to your individual situation. There's no charge. The call should take about 15 minutes. You can do that here.

If we both think proceeding can make a significant positive contribution to a favorable outcome, I'll prepare an in-depth report on the latest clinical trials, research papers and articles in leading medical journals. I subscribe to a number of the latest AI research tools, and will use those to comb through the sometimes tens of thousands of research sources to create a summary of what looks most promising and where those treatments are available. The cost of that report is $500.

From there, if you would like me to contact and interview physicians conducting those trials or medical scientists engaged in the most promising research, I'll prepare a plan for your consideration.

Research Services Summarized

Our work combines two research techniques:

What truly distinguishes Emerging Cures Research is its unique methodology: the powerful integration of artificial intelligence with direct, personal interviews of the world's leading medical researchers.

First, we use cutting-edge AI to scan thousands of medical publications and summarize the most relevant emerging science for your specific condition. AI excels at processing vast amounts of structured and unstructured data rapidly, identifying patterns and flagging potential leads that human researchers might overlook. AI, however, lacks the capacity for nuanced interviews, the interpretation of subtle cues, access to unpublished or nascent research, or the application of clinical intuition.

Those follow-up interviews make this research unique, useful, and powerful.

Research Into Survival Rates for Those Undergoing the Prevailing Standard of Care

What are the overall survival rates? What are the differentiating characteristics of those who survive long-term and those who don't, including treatments received, age, co-morbidities, exercise regimen, diet, etc.? A surprising amount of this data can be found in research at the National Institutes of Health and in university studies.

Research Into Emerging Treatments

Large numbers of trials of new drugs and new approaches to surgery and radiation are ongoing around the country, including research into the use of modified viruses that can stimulate the production of protective antibodies. There is research—often cited in the press but rarely available to patients—on the genetic analysis of particular cancers and individualized treatment strategies that appear likely to defeat specific diseases. Research using artificial intelligence can help identify where these options are available.

Research Into Alternative Treatments

I am not a proponent of most alternative treatments, including those espoused by naturopaths or by clinics in Mexico and South America. I will never suggest a cancer patient ignore modern medicine and focus solely on these alternatives. Pursuing them in addition to modern medicine is fine. I'm happy to research the actual supporting (or contradictory) data with an open mind. (Read more about my thoughts on alternative therapies here).

On the other hand, there are drugs that are not part of modern American medicine that have substantial data to support them. I am a believer, for instance, in Beta-Glucan, a drug widely used in Europe but that is not patentable and therefore not marketed to US physicians by US drug companies. I interviewed a researcher at Biothera, a Beta-Glucan manufacturer, years ago who told me that he was giving it to his mother who had non-Hodgkin's lymphoma with favorable results, and that the US government had stockpiled it to treat soldiers in the event they became exposed to radiation. This has significance since the side effects of radiation can severely impact one's immune system and thus leave us exposed to other pathogens and cancers. And, as I mentioned, the drug that may have saved my life, WF-10 (information here and here), also has properties that counter the negative effects of radiation. Both Beta Glucan and WF-10 dramatically boost the production of macrophages.

The Use of AI

AI will completely transform medical diagnosis and treatment over the next several years. Diseases will be much more accurately diagnosed by inputting blood test results and other diagnostic data into AI computer systems. Outcomes of different treatment regimens—what's working and what isn't—will be constantly fed into AI systems and updated minute by minute based on millions of incoming data points. Treatment protocols will be adjusted frequently, perhaps daily. I spend several hours most days using AI to identify experimental treatment options and leading experts in each cancer or disease area.

Helpful Habits and Behaviors: Fasting, Diet, Exercise

Lifestyle has a major effect on whether or not we get cancer. It probably has an impact on Alzheimer's disease (sleep habits, oral hygiene). After diagnosis, however, while certainly helpful and worth doing, lifestyle modification has the problem faced by many cancer therapies: the cancer cells that are susceptible to the treatment die, and those that are not susceptible replicate. I've known people who tried to deal with cancer solely through healthier choices. All died. I've read about survivors—for instance, in books about macrobiotics—but have never encountered an actual survivor. I note that the primary advocate of macrobiotics in the United States, Michio Kushi, his wife, and his daughter all died of cancer. Michio was 88 at the time of his death, which undoubtedly was a primary factor, but nevertheless, one should treat alternative treatments with skepticism unless backed by data.

Both my cancers occurred after long periods of overwork, fatigue, and inadequate sleep. I've since learned that lack of sleep can lead to many adverse health effects, including cancer and Alzheimer's disease. I've also learned that fasting for 14 hours out of every 24 can lead to major health improvements, including in those with cancer or dementia. Gut health—the promotion of life-sustaining bacteria—is another favorable element in good health and cancer recovery. Gut health is largely dependent upon a diet of fruits and vegetables and minimal sugar, red meat, and processed foods. The role of exercise in good health and in recovering from cancer is well documented. When I was first diagnosed with lymphoma, knowing what was ahead and how severe the strain would ultimately be on my body, I began an extreme exercise program that included running five miles each morning, push-ups, chin-ups, and sit-ups. It allowed me to survive the chemotherapy, I believe. I now walk an hour a day, rain or shine.

Many people are unwilling or unable to adopt major lifestyle changes. I ask clients if they are interested in the subject, and if they are not, I don't pursue it further. If they are interested, I send links to podcasts and other relevant research. I'm not exactly the poster boy role model myself. I'm overweight and have been for years. I stop drinking for months at a time, then start up again. Perfection is difficult to attain.

My focus, and my value to those on the cancer journey or dealing with other life-threatening diseases, is the search for difficult-to-obtain information that may have a major positive impact and, in fact, may be curative for those suffering from a life-threatening illness.

Who Emerging Cures Can't Help

There are three categories of patients not well suited to the approach I take:

• Patients who do not want to consider options or alternatives other than those suggested by their oncologist. When your prognosis is dire, my suggestion is to listen to anyone who has experience in cancer treatment and who has verifiable data to back up their opinions. If you are not open to other approaches, you and I are not a good match.

• My research and support services are for those who truly want to survive and live a quality life and are willing to make sacrifices to achieve that objective. Those sacrifices may, for instance, involve travel to one or more clinical trials.

• Patients who just want to focus on alternatives to modern medicine. Modern medicine isn't perfect, but it has a lot to offer. For one thing, even when modern medicine doesn't have a solution, practitioners are highly knowledgeable about the characteristics of particular diseases. I have found it absolutely crucial to listen to them, or to anyone who has a view based on data and knowledge. You never know when you will come across that crucial little insight that leads you in a worthwhile, potentially life-saving direction.

• Patients without health insurance. If you have been diagnosed with a potentially fatal disease and don't have health insurance, get it. Not having health insurance will lead to unwise decisions about options. Many, perhaps all, experimental cancer treatment trials require health insurance because providers can get reimbursement for that portion of the regimen that is considered standard care—blood tests, etc. If you can't afford health insurance, investigate Medicaid. You may qualify. The quality of care you get under Medicaid is no different from that you'd receive with private insurance. Insurance won't pay for my services, but my services may not be useful without it.

Quality of Life and Longevity (Not Versus Longevity)

Modern medicine will sometimes suggest courses of treatment that have an adverse impact on quality of life with no real prospect of recovery. These are treatment protocols that the oncologist himself or herself would refuse if they were diagnosed with the particular terminal disease. I assume they do this because they want to offer the patient and their loved ones some hope, even if not founded on data. Or they believe that life must be prolonged regardless of the suffering caused. Or they are attracted to the money generated by a fee-for-service system.

I'm here to try and find options that may result in improved quality of life and that may lead to recovery. If I know that none are available, or I come to that conclusion in the course of my research, I will immediately let you know.

Initial Consultation

We listen, then we create a plan based on your needs and overall situation. Solutions we offer can range from advising you of relevant information on emerging medical science specific to your condition when we come across it—which involves minimal expense on your part—to a comprehensive research service including interviews of leading specialists and medical researchers in your disease area and help identifying and then enrolling in particularly interesting clinical trials.

First, before we begin, we'll talk so that we can try to determine if we are suitable for working together with a reasonable prospect of a favorable outcome.